Genmab | GEN - Stock


Genmab reported DKK21M in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
Agios Pharmaceuticals USD 35.75M 665K Jun/2026
Almirall EUR 178.13M 1.54M Dec/2025
Amarin USD 164.07M 19.51M Jun/2026
Amgen USD 6.22B 34M Jun/2026
argenx SE USD 473.53M 132.91M Dec/2025
AstraZeneca USD 6.93B 362M Jun/2026
Bayer EUR 11.97B 43M Jun/2026
BioMarin Pharmaceutical USD 1.78B 509.3M Jun/2026
Demant DKK 2.62B 78M Dec/2025
Exelixis USD 28.73M 2.12M Jun/2026
Fresenius Medical Care EUR 2.33B 28.84M Jun/2026
Genmab DKK 21M 8M Mar/2026
GlaxoSmithKline GBP 6.16B 233M Mar/2026
GN Store Nord DKK 1.55B 763M Mar/2026
GRIFOLS EUR 3.49B 34M Jun/2026
Hikma Pharmaceutical USD 1.11B 24M Dec/2025
Insmed USD 142.38M 9.48M Jun/2026
Lakefront Biotherapeutics EUR 17.69M 4.8M Mar/2026
Lonza CHF 1.68B 163M Dec/2025
Merck EUR 4.78B 220M Mar/2026
Novartis USD 6.22B 66M Jun/2026
Regeneron Pharmaceuticals USD 3.08B 19.3M Jun/2026
Roche Holding CHF 7.6B 9M Jun/2025
Sanofi EUR 24.12B 620M Jun/2026
UCB EUR 1.31B 173M Dec/2024